USD 0.17
(8.57%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 15.12 Million USD | 43.4% |
2022 | 10.54 Million USD | 58.27% |
2021 | 6.66 Million USD | 53.08% |
2020 | 4.35 Million USD | 6.46% |
2019 | 4.08 Million USD | 5.99% |
2018 | 3.85 Million USD | 49.48% |
2017 | 2.58 Million USD | 0.0% |
2014 | 3.47 Million USD | -53.08% |
2013 | 7.39 Million USD | 92.64% |
2012 | 3.84 Million USD | -8.78% |
2011 | 4.21 Million USD | -42.64% |
2010 | 7.34 Million USD | -1.86% |
2009 | 7.48 Million USD | 0.93% |
2008 | 7.41 Million USD | 46.47% |
2007 | 5.05 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 9.18 Million USD | 103.26% |
2024 Q1 | 4.51 Million USD | -23.83% |
2023 FY | 15.12 Million USD | 43.4% |
2023 Q3 | 3.91 Million USD | 12.34% |
2023 Q4 | 5.93 Million USD | 51.77% |
2023 Q2 | 3.48 Million USD | 28.92% |
2023 Q1 | 2.69 Million USD | -12.92% |
2022 Q2 | 2.6 Million USD | 8.13% |
2022 Q1 | 2.4 Million USD | -7.68% |
2022 FY | 10.54 Million USD | 58.27% |
2022 Q4 | 3.1 Million USD | 27.16% |
2022 Q3 | 2.43 Million USD | -6.29% |
2021 Q2 | 1.25 Million USD | 13.12% |
2021 Q1 | 1.1 Million USD | -11.35% |
2021 FY | 6.66 Million USD | 53.08% |
2021 Q4 | 2.6 Million USD | 53.91% |
2021 Q3 | 1.69 Million USD | 34.98% |
2020 Q4 | 1.25 Million USD | 28.32% |
2020 Q2 | 1.09 Million USD | 6.1% |
2020 FY | 4.35 Million USD | 6.46% |
2020 Q1 | 1.03 Million USD | -21.52% |
2020 Q3 | 975 Thousand USD | -10.96% |
2019 Q1 | 904 Thousand USD | 22.0% |
2019 Q3 | 931 Thousand USD | -0.75% |
2019 Q4 | 1.31 Million USD | 41.25% |
2019 FY | 4.08 Million USD | 5.99% |
2019 Q2 | 938 Thousand USD | 3.76% |
2018 Q1 | 741 Thousand USD | -25.75% |
2018 Q4 | 741 Thousand USD | 4.96% |
2018 Q3 | 706 Thousand USD | -57.78% |
2018 Q2 | 1.67 Million USD | 125.64% |
2018 FY | 3.85 Million USD | 49.48% |
2017 Q4 | 998 Thousand USD | 87.59% |
2017 Q2 | 620.99 Thousand USD | -6.05% |
2017 Q1 | 661 Thousand USD | 0.0% |
2017 FY | 2.58 Million USD | 0.0% |
2017 Q3 | 532 Thousand USD | -14.33% |
2015 Q1 | 988.54 Thousand USD | 20.84% |
2014 FY | 3.47 Million USD | -53.08% |
2014 Q2 | 1.26 Million USD | 142.96% |
2014 Q1 | 521.61 Thousand USD | -45.0% |
2014 Q4 | 818.04 Thousand USD | -45.6% |
2014 Q3 | 1.5 Million USD | 18.65% |
2013 Q3 | 734.26 Thousand USD | -6.82% |
2013 Q4 | 948.46 Thousand USD | 29.17% |
2013 FY | 7.39 Million USD | 92.64% |
2013 Q1 | 5.69 Million USD | 1016.34% |
2013 Q2 | 788.03 Thousand USD | -86.16% |
2012 Q3 | 406.55 Thousand USD | -74.81% |
2012 Q4 | 510.07 Thousand USD | 25.46% |
2012 FY | 3.84 Million USD | -8.78% |
2012 Q1 | 843.76 Thousand USD | 17.67% |
2012 Q2 | 1.61 Million USD | 91.26% |
2011 Q3 | 665.75 Thousand USD | -27.57% |
2011 Q1 | 990.61 Thousand USD | -7.38% |
2011 Q4 | 717.07 Thousand USD | 7.71% |
2011 Q2 | 919.12 Thousand USD | -7.22% |
2011 FY | 4.21 Million USD | -42.64% |
2010 FY | 7.34 Million USD | -1.86% |
2010 Q2 | 3.76 Million USD | 245.95% |
2010 Q1 | 1.08 Million USD | 17.52% |
2010 Q4 | 1.06 Million USD | -13.14% |
2010 Q3 | 1.23 Million USD | -67.33% |
2009 Q4 | 926.99 Thousand USD | -61.25% |
2009 FY | 7.48 Million USD | 0.93% |
2009 Q3 | 2.39 Million USD | -42.06% |
2009 Q2 | 4.12 Million USD | 252.16% |
2009 Q1 | 1.17 Million USD | 16.81% |
2008 Q4 | 1 Million USD | -14.14% |
2008 Q3 | 1.16 Million USD | -63.93% |
2008 Q1 | 1.25 Million USD | -70.86% |
2008 Q2 | 3.24 Million USD | 157.8% |
2008 FY | 7.41 Million USD | 46.47% |
2007 Q2 | 2 Million USD | 74.41% |
2007 Q3 | 1.3 Million USD | -35.03% |
2007 FY | 5.05 Million USD | 0.0% |
2007 Q4 | 4.31 Million USD | 231.84% |
2007 Q1 | 1.14 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Achiko AG | 6.78 Million USD | -122.901% |
Accelera Innovations, Inc | - USD | -Infinity% |
Aspyra Inc. | 8.04 Million USD | -88.047% |
Cannabis Sativa, Inc. | 862.24 Thousand USD | -1654.039% |
CompuMed, Inc. | 2.91 Million USD | -418.412% |
CompuGroup Medical SE & Co. KGaA | 1 Billion USD | 98.495% |
Cogstate Limited | 23.64 Million USD | 36.026% |
CareView Communications, Inc. | 7.21 Million USD | -109.495% |
Craneware plc | 141.35 Million USD | 89.3% |
Caduceus Software Systems Corp. | 2.07 Million USD | -627.354% |
Certive Solutions Inc. | 1.5 Million USD | -902.518% |
Drug Free Solution, Inc. | 1.39 Million USD | -983.595% |
DATATRAK International, Inc. | 3.26 Million USD | -362.717% |
Strainsforpains, Inc. | 149.72 Thousand USD | -10001.375% |
Healixa Inc. | 6.56 Million USD | -130.4% |
Easy Technologies Inc. | - USD | -Infinity% |
eWellness Healthcare Corporation | - USD | -Infinity% |
Founders Bay Holdings | 3.28 Million USD | -360.981% |
Health Discovery Corporation | - USD | -Infinity% |
Healthcare Integrated Technologies, Inc. | 702.92 Thousand USD | -2051.599% |
H-Source Holdings Ltd. | - USD | -Infinity% |
InterCare DX, Inc. | 491.28 USD | -3078405.333% |
IQ-AI Limited | 1.13 Million USD | -1236.881% |
Cannabiz Mobile, Inc. | 750.00 USD | -2016444.133% |
Mednow Inc. | 2.78 Million USD | -443.37% |
Galileo Life Sciences, Inc. | 270.72 Thousand USD | -5486.552% |
MediXall Group, Inc. | 59.26 Thousand USD | -25418.123% |
Mitesco, Inc. | 2.58 Million USD | -484.694% |
MobileSmith, Inc. | 8.63 Million USD | -75.075% |
NantHealth, Inc. | 94.47 Million USD | 83.992% |
Net Medical Xpress Solutions, Inc. | 1.76 Million USD | -758.835% |
OneLife Technologies Corp. | - USD | -Infinity% |
ORHub, Inc. | 12.38 Million USD | -22.143% |
Patient Access Solutions, Inc. | 9.19 Million USD | -64.511% |
Pharma-Bio Serv, Inc. | 3.94 Million USD | -282.985% |
PPJ Healthcare Enterprises, Inc. | 141.33 Thousand USD | -10600.647% |
Medical Cannabis Payment Solutions, Inc. | 12.18 Thousand USD | -124030.671% |
Renalytix Plc | 29.04 Million USD | 47.922% |
Revium Recovery Inc. | 677 Thousand USD | -2133.985% |
RYAH Group, Inc. | - USD | -Infinity% |
Carepay Inc. | 369.00 USD | -4098566.938% |
Vaso Corporation | 46.39 Million USD | 67.404% |
Vynleads, Inc. | 200.15 Thousand USD | -7456.147% |